The Danish Health Authority temporarily suspends the use of the Oxford-AstraZeneca vaccine for two weeks as a "precaution" following reports that some vaccinated people had experienced blood clots, causing one person to die after receiving the vaccine. It has not been determined whether there is a link between the vaccine and the clots. Norway and Iceland have also suspended their use of the vaccine.